SPP1-CD44-Mediated Crosstalk Between Endothelial and Macrophage Subpopulations Promotes Pancreatic Ductal Adenocarcinoma Progression Through S100A6 Upregulation
Cells · 2026
DOI: 10.3390/cells15201844 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cells, 2026. Verfasst von Yanbin Zhou und 3 weiteren Autor:innen. Beteiligte Einrichtung: Xiangya School of Pharmaceutical Sciences, Central South University, Changsha 410013, China. Hauptthemen laut MEDLINE: Carcinoma, Pancreatic Ductal, Pancreatic Neoplasms, Endothelial Cells, Disease Progression. Die Arbeit nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Department of Science and Technology of Hunan Province, Natural Science Foundation of Hunan Province.
Abstract (Originalsprache)
Pancreatic ductal adenocarcinoma (PDAC) progression is driven by complex cellular interactions within the tumor microenvironment (TME), where endothelial cell (EC)-tumor-associated macrophage (TAM) crosstalk significantly influences angiogenesis and immune modulation, although the specific subsets and consequences remain unclear. Here, we integrated four single-cell RNA sequencing datasets (50 PDAC; 21 normal adjacent tissues) to profile EC and macrophage subpopulations, subsequently employing CellChat to decipher intercellular communication networks and identify altered ligand–receptor interactions in PDAC. Correlation and Kaplan–Meier survival analyses (TCGA-PAAD) assessed associations and prognostic value, while functional validation used EdU, CCK-8, and Transwell assays on PDAC cells. We identified a distinct endothelial subset (EC0) and macrophage subset (Mac2) with enhanced interaction signals in PDAC. This EC0–Mac2 crosstalk correlated with significant S100A6 upregulation, which was associated with poor patient prognosis. Exogenous S100A6 treatment markedly enhanced PDAC cell proliferation and migration in vitro. In conclusion, EC-Mac crosstalk may promote PDAC progression via S100A6, and this interaction pattern warrants further investigation as a candidate prognostic biomarker and potential target for disrupting stromal communication.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Xiangya School of Pharmaceutical Sciences, Central South University, Changsha 410013, China.
- School of Traditional Chinese Medicine, Shandong University of Traditional Chinese Medicine, Jinan 250355, China.
- Faculty of Chinese Medicine, Medical Sciences Division, Macau University of Science and Technology, Macau 999078, China.
- Hunan Key Laboratory of The Research and Development of Novel Pharmaceutical Preparations, School of Pharmaceutical Science, Changsha Medical University, Changsha 410219, China.
ORCID-Profile: Wenhu Zhou
Förderung
- Department of Science and Technology of Hunan Province
- Natural Science Foundation of Hunan Province
Zitieren
APA
Zhou, Y., Guo, S., Zhou, W., & Wang, W. (2026). SPP1-CD44-Mediated Crosstalk Between Endothelial and Macrophage Subpopulations Promotes Pancreatic Ductal Adenocarcinoma Progression Through S100A6 Upregulation. Cells. https://doi.org/10.3390/cells15201844
Vancouver
Zhou Y, Guo S, Zhou W, Wang W. SPP1-CD44-Mediated Crosstalk Between Endothelial and Macrophage Subpopulations Promotes Pancreatic Ductal Adenocarcinoma Progression Through S100A6 Upregulation. Cells. 2026. doi:10.3390/cells15201844
BibTeX
@article{Zhou2026,
author = {Zhou, Yanbin and Guo, Sixian and Zhou, Wenhu and Wang, Wei},
title = {SPP1-CD44-Mediated Crosstalk Between Endothelial and Macrophage Subpopulations Promotes Pancreatic Ductal Adenocarcinoma Progression Through S100A6 Upregulation},
journal = {Cells},
year = {2026},
doi = {10.3390/cells15201844}
}
EUVIMED